Biotechnology is a key interdisciplinary technology that continues to increase in significance. However, the question of reliable financing is still a topic that moves the industry. Which is one more reason to get tips from experts at analytica Finance Day.
The 4th Finance Day, which is organized by GoingPublic Media, will explore these and other questions on the third day of the fair (April 3, 2014).
Topics at a glance:
- Panel 1
Early-phase financing/Venture capital: "Challenge accepted!?
Who is still investing in biotech start-ups?" - Panel 2
"Cooperation between Big Pharma and biotech—Partnership or compromise solution?" - Panel 3
Bio-economy: "More than industrial biotechnology or a buzzword?" - Panel 4
Biotech companies that are listed on the stock exchange: "Is biotech "in" again with investors?"
| On April 4th, analytica addresses the issue of personalized medicine: |
What has been achieved in the field of individual, stratified treatment. Where come the new technologies to their limits? Does personalized medicine already reach the patient? Is the development rather slowed down by the regulatory, science or refund? And the crowds will fill the halls again when it comes to the next "jobvector career day" on the very last day of Analytica. BioM gives you the free ticket for this very special show! Further information and the programme can be found at: |